Evidence map›Paper›PMID 40463375›Full record

ArticleFrontiers in immunology2025

SIV/SARS-CoV-2 coinfection in rhesus macaques impacts viral shedding, host immunity, the microbiome, and viral evolution.

Megan N Fredericks, Zohar Kolodner, Adam Waalkes, Kaitlin Sawatzki, Linhui Hao, Dustin R Long, Kelsi Penewit, Cecily C Midkiff, Carter J McCormick, Semira Beraki and 8 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Megan N FredericksDepartment of Microbiology, University of Washington, Seattle, WA, United States.
Zohar KolodnerDepartment of Microbiology, University of Washington, Seattle, WA, United States.
Adam WaalkesDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
Kaitlin SawatzkiDepartment of Immunology, University of Washington, Seattle, WA, United States.
Linhui HaoDepartment of Immunology, University of Washington, Seattle, WA, United States.
Dustin R LongDivision of Critical Care Medicine, Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, WA, United States.
Kelsi PenewitDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
Cecily C MidkiffTulane National Primate Research Center, Covington, LA, United States.
Carter J McCormickDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
Semira BerakiDepartment of Microbiology, University of Washington, Seattle, WA, United States.
Paul T EdlefsenFred Hutchinson Cancer Research Center, Seattle, WA, United States.
Jeana BarrowWashington National Primate Research Center, Seattle, WA, United States.
Alexander L GreningerDepartment of Immunology, University of Washington, Seattle, WA, United States.
Michael GaleWashington National Primate Research Center, Seattle, WA, United States.
Robert V BlairDivision of Critical Care Medicine, Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, WA, United States.
Stephen J SalipanteDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
Deborah H FullerDepartment of Microbiology, University of Washington, Seattle, WA, United States.
Megan A O'ConnorDepartment of Microbiology, University of Washington, Seattle, WA, United States.

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
Evaluating risks of ZIKV co-infection in SIV-infected macaquesK01MH123258 · NIMH · UNIVERSITY OF WASHINGTON · PI O'CONNOR, MEGAN A · 2020 to 2022
$346k
Automated Staining Platform for Immunohistochemistry and In Situ HybridizationS10OD030347 · OD · TULANE UNIVERSITY OF LOUISIANA · PI BLAIR, ROBERT · 2021 to 2021
$228k
NIH HHS P51 OD010425NIH HHS P51 OD011104NIH HHS S10 OD030347NIMH NIH HHS K01 MH123258
6 · The paper itself

Abstract

People living with HIV (PLWH) have an increased risk of severe COVID-19, including prolonged viral shedding and emergence of mutations. To investigate the simian immunodeficiency virus (SIV) macaque model for HIV/SARS-CoV-2 coinfection, seven SIV+ rhesus macaques were co-infected with SARS-CoV-2. COVID-19 in all macaques was mild. SARS-CoV-2 replication persisted in the upper, but not the lower respiratory tract for 14 days post-infection. Animals showed impaired generation of anti-SARS-CoV-2 antibodies and T-cells. Animals also displayed transient changes in microbial communities in the upper airway and gastrointestinal tract. Evidence of SARS-CoV-2 evolution was observed in the upper respiratory tract. This study demonstrates that SIV/SARS-CoV-2 coinfection in rhesus macaques recapitulates aspects of COVID-19 in PLWH. We show that SIV impairs anti-SARS-CoV-2 immunity, potentially leading to prolonged viral shedding, altered pathogenesis, and viral evolution. This highlights the importance of HIV status in COVID-19 and supports the use of this model for HIV/SARS-CoV-2 coinfection.

Indexed as

CoinfectionCOVID-19MicrobiotaSARS-CoV-2Simian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusVirus SheddingAnimalsAntibodies, ViralDisease Models, AnimalMacaca mulattaAntibodies, ViralAIDSCOVID-19HIVimmunocompromisedimmunodeficiencynonhuman primate

Identifiers

PMID40463375
PMCPMC12129928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.